3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Cycling
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Substance-Related Disorders
1
Smoldering Multiple Myeloma
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Motor Activity
1
Mental Disorders
1
Insulin Resistance
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Head and Neck Carcinoma
1
Genital Neoplasms, Female
1
Interventions
Cyclophosphamide
43
venetoclax
30
Cytarabine
25
fludarabine
22
fludarabine phosphate
17
Azacitidine
16
Mycophenolic Acid
13
Whole-Body Irradiation
12
Dexamethasone
12
Rituximab
11
Busulfan
11
ruxolitinib
10
Vincristine
10
Methotrexate
10
Etoposide
10
Tacrolimus
9
Mercaptopurine
9
Daunorubicin
9
Prednisone
8
Filgrastim
8
Dasatinib
8
ibrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Granulocyte Colony-Stimulating Factor
7
Doxorubicin
7
Decitabine
7
pegaspargase
6
blinatumomab
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Behavior Therapy
×
1 year
×
Clear all
No trials found.